HUMAN CD5+ (B1) B-CELLS IN HEALTH AND DISEASE

被引:0
|
作者
LYDYARD, PM [1 ]
YOUINOU, PY [1 ]
机构
[1] BREST UNIV HOSP, SCH MED, IMMUNOL LAB, BREST, FRANCE
来源
FUNDAMENTAL AND CLINICAL IMMUNOLOGY | 1994年 / 2卷 / 01期
关键词
CD5; B-CELLS; B1-CELLS; NATURAL ANTIBODIES; CLL; AUTOIMMUNE DISEASES;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD5 B cells (B1 cells) are the first B cells to be produced during ontogeny and usually utilise minimally mutated germ-line genes. They are mainly of the IgM class but may also express IgG and IgA. They produce low avidity auto and polyreactive antibodies (natural antibodies). There is evidence for and against B1 cells being a separate lineage. B1 cells probably play a role in setting up the idiotype network, antigen presentation and tolerance induction. Their relative importance of each of these different functions in maintaining an effective normal immune system is unclear. Chronic lymphocytic leukemia is a malignancy of the B1 population and Rheumatoid Arthritis probabLy represents an abnormal antigen-driven maturation of specific self-reactive anti-IgGFc clones. Since B1 cells are regulated by cytokines, other autoimmune diseases including some organ specific diseases where there is an increase in CD5 B cells, may represent abnormal cytokine regulation.
引用
收藏
页码:9 / 25
页数:17
相关论文
共 50 条
  • [41] CD5+ B-CELLS AND CD4-8- T-CELLS IN NEUROIMMUNOLOGICAL DISEASES
    CORREALE, J
    MIX, E
    OLSSON, T
    KOSTULAS, V
    FREDRIKSON, S
    HOJEBERG, B
    LINK, H
    JOURNAL OF NEUROIMMUNOLOGY, 1991, 32 (02) : 123 - 132
  • [42] Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells
    Tangye, SG
    Weston, KM
    Raison, RL
    LEUKEMIA & LYMPHOMA, 1998, 31 (1-2) : 121 - 130
  • [43] FEEDBACK SUPPRESSION OF NORMAL AND LEUKEMIC B-CELL COLONY GROWTH BY CD5+ B-CELLS
    FERNANDEZ, LA
    MACSWEEN, JM
    ROBSON, DA
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 628 : 379 - 381
  • [44] Theileria annulata in CD5+ macrophages and B1B cells
    Moreau, MF
    Thibaud, JL
    Ben Miled, L
    Chaussepied, M
    Baumgartner, M
    Davis, WC
    Minoprio, P
    Langsley, G
    INFECTION AND IMMUNITY, 1999, 67 (12) : 6678 - 6682
  • [45] DECREASED FREQUENCY OF B1 (CD5+) CELLS IN MURINE AIDS AND CHRONIC GRAFT-VS-HOST DISEASE
    ICIEK, LA
    WALDSCHMIDT, TJ
    GRIFFITHS, MM
    BROOKS, KH
    FASEB JOURNAL, 1992, 6 (05): : A1988 - A1988
  • [46] RECONSTITUTION OF XID MICE WITH DONOR CELLS ENRICHED FOR CD5+ B-CELLS RESTORES CONTRASUPPRESSION
    PECQUET, SS
    ZAZULAK, J
    SIMPSON, SD
    ERNST, PB
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 173 - 175
  • [47] CD5+ B-CELLS IN NORMAL NEWBORNS AND INFANTS, AND IN THOSE WITH HIV AND INTRAUTERINE INFECTIONS
    IBEGBU, CC
    NAHMIAS, AJ
    SPIRA, TJ
    STOLL, BJ
    JONES, B
    SYMBAS, N
    NESHEIM, S
    MENDEZ, H
    KEYSERLING, H
    LEE, FK
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 572 - 575
  • [48] REGULATION OF DIFFERENTIATION IN CD5+ AND CONVENTIONAL B-CELLS BY LPS AND IFN-GAMMA
    CHACE, JH
    ABED, NS
    ADEL, GL
    COWDERY, JS
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 192 - 192
  • [49] ABNORMALITIES IN IMMUNOREGULATORY CD5+ B-CELLS PRECEDE THE DIAGNOSIS OF MULTIPLE-MYELOMA
    PAGLIERONI, T
    MACKENZIE, MR
    CAGGIANO, V
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 651 : 486 - 487
  • [50] CD5+ B-CELLS AND NATURALLY-OCCURRING AUTOANTIBODIES IN CANCER-PATIENTS
    STEIN, R
    WITZ, IP
    OVADIA, J
    GOLDENBERG, DM
    YRON, I
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 85 (03): : 418 - 423